AI assistant
Sending…
FIBROGEN INC — Director's Dealing 2015
Dec 30, 2015
34576_dirs_2015-12-30_efac692c-95b1-4551-8aae-462be0f016e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2015-12-28
Reporting Person: Routti Jorma (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-28 | Common Stock | M | 8000 | $2.00 | Acquired | 115840 | Direct |
| 2015-12-28 | Common Stock | M | 12000 | $4.025 | Acquired | 127840 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-28 | Stock Option (Right to Buy) | $2.00 | M | 8000 | Disposed | 2016-03-01 | Common Stock (8000) | Direct |
| 2015-12-28 | Stock Option (Right to Buy) | $4.025 | M | 12000 | Disposed | 2017-08-20 | Common Stock (12000) | Direct |
Footnotes
F1: Fully vested and exercisable.
F2: Not applicable.
More from FIBROGEN INC
Regulatory Filings
2026
Apr 9
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Nov 17
Major Shareholding Notification
2025
Nov 15
Interim / Quarterly Report
2025
Nov 10
Regulatory Filings
2025
Nov 10